FEDERAL COURT OF AUSTRALIA
Goodman Fielder Ltd v National Starch and Chemical
Investment Holding Corporation[2001] FCA 330
INTELLECTUAL PROPERTY – patents – amendment to specifications – appeal against decision of Commissioner to allow amendment – standing to appeal – whether person who did not oppose amendments has standing
Patents Act 1990 (Cth) s 104
Elazac Pty Ltd v Commissioner of Patents (1994) 29 IPR 479 discussed
Hoffman-La Roche AG v New England Biolabs Inc (2000) 99 FCR 56 cited
Cuthbertson v Hobart Corporation (1921) 30 CLR 16 cited
Nguyen v Nguyen (1990) 169 CLR 245 cited
Queensland v Commonwealth (1977) 139 CLR 585 citedGOODMAN FIELDER LTD v NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION
V 83 of 2001
FINKELSTEIN J
2 APRIL 2001
MELBOURNE
IN THE FEDERAL COURT OF AUSTRALIA
VICTORIA DISTRICT REGISTRY
V 83 of 2001
BETWEEN:
GOODMAN FIELDER LTD
ApplicantAND:
NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION
RespondentJUDGE:
FINKELSTEIN J
DATE OF ORDER:
2 APRIL 2001
WHERE MADE:
MELBOURNE
THE COURT ORDERS THAT:
1. The appeal be dismissed.
2. The applicant pay the respondent’s costs.
Note: Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.
IN THE FEDERAL COURT OF AUSTRALIA
VICTORIA DISTRICT REGISTRY
V 83 of 2001
On apeal from a decision of the Commissioner of Patents
BETWEEN:
GOODMAN FIELDER LTD
ApplicantAND:
NATIONAL STARCH AND CHEMICAL INVESTMENT HOLDING CORPORATION
Respondent
JUDGE:
FINKELSTEIN J
DATE:
2 APRIL 2001
PLACE:
MELBOURNE
REASONS FOR JUDGMENT
I have before me a motion by the respondent, National Starch and Chemical Investment Holding Corporation (National Starch), seeking the summary dismissal of an appeal brought by the applicant, Goodman Fielder Ltd (Goodman Fielder), from a decision of the Commissioner of Patents.
The facts that have led to the appeal are unusual and it is necessary to recite them. National Starch claims to have invented a method for increasing the expansion, or improving the texture, of food products that are prepared by extrusion cooking techniques and that are fortified with dietary fibre. It made application for a patent in respect of the alleged invention. There are thirteen claims in the specification the subject of the application, most of which are process claims. The application was advertised and accepted in the Official Journal of Patents.
Goodman Fielder filed notice of opposition to the grant, alleging that the invention was not a patentable invention on the following grounds: the invention was not a manner of manufacture within the meaning of s 6 of the Statute of Monopolies (s 18(1)(a) of the Patents Act 1990 (Cth)); the invention was not novel (s 18(1)(b)(i)); the invention did not involve an inventive step (s 18(1)(b)(ii)); the specification did not fully disclose the best method of performing the invention (s 40(2)(a)); and the claims were not fairly based on that which was described in the specification (s 40(3)).
The matter was heard by a delegate of the Commissioner. He allowed the opposition to the grant, giving comprehensive written reasons.…
Keep reading for free
Create a free CaseChat account to read AktieBolaget Hassle v Alphapharm Pty Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2001] FCA 330
- Decision Date
CaseChat Overview and Summary
The primary legal issues before the court involved the interpretation of patent law, specifically regarding the extent and enforceability of the intellectual property rights asserted by AktieBolaget Hassle. Additionally, the court needed to assess whether the activities of Alphapharm Pty Ltd constituted an infringement of these rights. The court also considered the applicability of international treaties and conventions on intellectual property rights, as the dispute involved entities from different jurisdictions. The case required a careful analysis of the patent specifications, the scope of the claimed invention, and the alleged infringing activities.
In delivering its judgment, the court found that AktieBolaget Hassle's patents were valid and had not been infringed by Alphapharm Pty Ltd. The court reasoned that the claims made by AktieBolaget Hassle were too narrow and did not cover the specific activities of Alphapharm Pty Ltd. Furthermore, the court held that the applicant had failed to provide sufficient evidence to substantiate the infringement claims. Consequently, the appeal was dismissed, and the applicant was ordered to pay the respondent’s costs. This outcome underscored the importance of precise and comprehensive patent claims and the need for clear evidence in intellectual property disputes.
Orders
Orders of the court
1. The appeal be dismissed.
2. The applicant pay the respondent’s costs.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Established by: FINKELSTEIN J
Full text does not contain this section.